dc.contributor.author | McLean, Mairi H. | |
dc.contributor.author | Andrews, Caroline | |
dc.contributor.author | Hanson, Miranda L. | |
dc.contributor.author | Baseler, Walter A. | |
dc.contributor.author | Anver, Miriam R. | |
dc.contributor.author | Senkevitch, Emilee | |
dc.contributor.author | Staniszewska , Aleksandra K. | |
dc.contributor.author | Davies, Luke C. | |
dc.contributor.author | Hixon, Julie | |
dc.contributor.author | Li, Wenqeng | |
dc.contributor.author | Shen, Wei | |
dc.contributor.author | Steidler, Lothar | |
dc.contributor.author | Durum, Scott K. | |
dc.date.accessioned | 2018-10-08T23:07:06Z | |
dc.date.available | 2018-10-08T23:07:06Z | |
dc.date.issued | 2017-11 | |
dc.identifier.citation | McLean , M H , Andrews , C , Hanson , M L , Baseler , W A , Anver , M R , Senkevitch , E , Staniszewska , A K , Davies , L C , Hixon , J , Li , W , Shen , W , Steidler , L & Durum , S K 2017 , ' Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses ' , Inflammatory Bowel Diseases , vol. 23 , no. 11 , pp. 1983-1995 . https://doi.org/10.1097/MIB.0000000000001274 | en |
dc.identifier.issn | 1078-0998 | |
dc.identifier.other | PURE: 105451832 | |
dc.identifier.other | PURE UUID: 6723d161-08fe-4ef8-a02a-da01fb10c1bc | |
dc.identifier.other | PubMed: 29019857 | |
dc.identifier.other | Scopus: 85040722980 | |
dc.identifier.other | ORCID: /0000-0002-7443-2653/work/76974181 | |
dc.identifier.uri | http://hdl.handle.net/2164/11227 | |
dc.description | This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, as well as a fellowship funded by Crohn’s and Colitis Foundation of America (MHM) and a grant from the Broad Medical Research Foundation. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E (MRA). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Inflammatory Bowel Diseases | en |
dc.rights | https://creativecommons.org/licenses/by-nc/4.0/ | en |
dc.subject | interleukin-27 | en |
dc.subject | cytokine | en |
dc.subject | IBD | en |
dc.subject | colitis | en |
dc.subject | R Medicine (General) | en |
dc.subject.lcc | R1 | en |
dc.title | Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1097/MIB.0000000000001274 | |
dc.date.embargoedUntil | 2018-10-09 | |
dc.identifier.vol | 23 | en |
dc.identifier.iss | 11 | en |